Global Hutchinson-Gilford Progeria Syndrome (HGPS) market size is expected to reach $160 billion by 2030 at 8.5%, the increase in funding for research and development drives market growth
Read More
Global Huntington’s Disease market size is expected to reach $1.22 Billion by 2030 at 17.5%, rising neurological disorders fueling the growth of the market due to increasing diagnosis and aging population
Read More
Global Humira Biosimilar market size is expected to reach $6.53 by 2030 at 12.2%, the increasing prevalence of autoimmune diseases is fueling the growth of the market due to rising demand for tnf-blocking therapies
Read More
The Humanized Antibody market size is expected to reach $72.47 billion in 2030 at 12.7%, driven by rising incidence of cancer.
Read More
Global Human Respiratory Syncytial Virus Treatment market size is expected to reach $2.76 billion by 2030 at 8.5%, expansion of telehealth solutions fueling the growth of the market due to increasing adoption of digital healthcare technologies
Read More
Global Human Primary Cell Culture market size is expected to reach $6.39 billion by 2030 at 11%, growing emphasis on cell and gene therapies driving the market due to increasing demand for personalized regenerative treatments
Read More
Global Human Papillomavirus hpv Cytomegalovirus cmvTherapeutic market size is expected to reach $7.32 by 2030 at 8.4%, increasing prevalence of cervical cancer fuelling the growth of the market due to low hpv vaccination coverage
Read More
Global Human Organoids market size is expected to reach $3.61 billion by 2030 at 16.1%, rising genetic research experiments fueling the growth of the market due to advancements in stem cell and gene editing technologies
Read More
Global Human Metapneumovirus Diagnostics market size is expected to reach $0.86 by 2030 at 9.9%, surge in respiratory infections fueling the growth of the market due to increased vulnerability and need for early detection
Read More
Global Human Metapneumovirus (hMPV) Therapeutics market size is expected to reach $0.94 billion by 2030 at 6%, rising respiratory infections fueling growth of the human metapneumovirus (hmpv) therapeutics market due to increasing vulnerability among key populations
Read More